Clinical features and long-term prognosis of patients with congestive heart failure taking tolvaptan: a comparison of patients with preserved and reduced left ventricular ejection fraction

Few studies have investigated the clinical benefit of the long-term use of tolvaptan (TLV) for heart failure (HF). This study evaluated the long-term prognosis of patients administered TLV for > 1 year among patients who had HF with preserved ejection fraction (HFpEF) and those who had HF with re...

Descripción completa

Detalles Bibliográficos
Autores principales: Seki, Toshiki, Kubota, Yoshiaki, Matsuda, Junya, Tokita, Yukichi, Iwasaki, Yu-ki, Shimizu, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917027/
https://www.ncbi.nlm.nih.gov/pubmed/34648064
http://dx.doi.org/10.1007/s00380-021-01957-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917027/
https://www.ncbi.nlm.nih.gov/pubmed/34648064
http://dx.doi.org/10.1007/s00380-021-01957-1

Ejemplares similares